Regulation of platelet adenylate cyclase by adenosine.
The stimulatory and inhibitory effects of adenosine on the adenylate cyclases of human and pig platelets were studied. Stimulation occurred at lower concentrations than did inhibition, and the stimulatory effect was prevented by methylxanthines. Stimulation by adenosine was immediate in onset and was reversible, under conditions when cyclic AMP formation was linear with respect to time and protein concentration. The stimulatory and inhibitory effects could be distinguished further by the use of various analogues of adenosine and could be prevented by adenosine deaminase. The data suggest that both stimulation and inhibition were due to adenosine itself and not one of its degradation products and that in the platelet preparation, neither formation nor degradation of adenosine during the adenylate cyclase incubation appreciably influenced measured activity. Stimulation by adenosine was additive with the effects of GMP-P(NH)P, and alpha- or beta-adrenergic stimulation, but was abolished by prostaglandin E1 or by NaF. Prostaglandin E1 and NaF increased the sensitivity of adenylate cyclase to inhibition by adenosine. The data suggest that guanyl-5'-yl-(beta-gamma-imino)diphosphate and/or adrenergic stimulation and adenosine exert their effects on adenylate cyclase by distinct mechanisms, but that prostaglandin E1 or F- and adenosine increase enzyme activity by mechanisms which may involve common intermediates in the coupling to adenylate cyclase.
D000241:Adenosine / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000243:Adenosine Deaminase / Q000494:pharmacology; D000262:Adenylyl Cyclases / Q000097:blood*; D000818:Animals; D001792:Blood Platelets / Q000201:enzymology*; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D006801:Humans; D011458:Prostaglandins E / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000378:metabolism; D012969:Sodium Fluoride / Q000494:pharmacology; D013552:Swine; D014970:Xanthines / Q000494:pharmacology
D011458:Prostaglandins E; D011941:Receptors, Adrenergic; D014970:Xanthines; D006165:Guanylyl Imidodiphosphate; D012969:Sodium Fluoride; D000243:Adenosine Deaminase; D000262:Adenylyl Cyclases; D000241:Adenosine